Correlation Between City View and Acorda Therapeutics
Can any of the company-specific risk be diversified away by investing in both City View and Acorda Therapeutics at the same time? Although using a correlation coefficient on its own may not help to predict future stock returns, this module helps to understand the diversifiable risk of combining City View and Acorda Therapeutics into the same portfolio, which is an essential part of the fundamental portfolio management process.
By analyzing existing cross correlation between City View Green and Acorda Therapeutics, you can compare the effects of market volatilities on City View and Acorda Therapeutics and check how they will diversify away market risk if combined in the same portfolio for a given time horizon. You can also utilize pair trading strategies of matching a long position in City View with a short position of Acorda Therapeutics. Check out your portfolio center. Please also check ongoing floating volatility patterns of City View and Acorda Therapeutics.
Diversification Opportunities for City View and Acorda Therapeutics
0.38 | Correlation Coefficient |
Weak diversification
The 3 months correlation between City and Acorda is 0.38. Overlapping area represents the amount of risk that can be diversified away by holding City View Green and Acorda Therapeutics in the same portfolio, assuming nothing else is changed. The correlation between historical prices or returns on Acorda Therapeutics and City View is a relative statistical measure of the degree to which these equity instruments tend to move together. The correlation coefficient measures the extent to which returns on City View Green are associated (or correlated) with Acorda Therapeutics. Values of the correlation coefficient range from -1 to +1, where. The correlation of zero (0) is possible when the price movement of Acorda Therapeutics has no effect on the direction of City View i.e., City View and Acorda Therapeutics go up and down completely randomly.
Pair Corralation between City View and Acorda Therapeutics
If you would invest 0.51 in City View Green on September 17, 2024 and sell it today you would earn a total of 0.84 from holding City View Green or generate 164.71% return on investment over 90 days.
Time Period | 3 Months [change] |
Direction | Moves Together |
Strength | Very Weak |
Accuracy | 1.54% |
Values | Daily Returns |
City View Green vs. Acorda Therapeutics
Performance |
Timeline |
City View Green |
Acorda Therapeutics |
Risk-Adjusted Performance
0 of 100
Weak | Strong |
Very Weak
City View and Acorda Therapeutics Volatility Contrast
Predicted Return Density |
Returns |
Pair Trading with City View and Acorda Therapeutics
The main advantage of trading using opposite City View and Acorda Therapeutics positions is that it hedges away some unsystematic risk. Because of two separate transactions, even if City View position performs unexpectedly, Acorda Therapeutics can make up some of the losses. Pair trading also minimizes risk from directional movements in the market. For example, if an entire industry or sector drops because of unexpected headlines, the short position in Acorda Therapeutics will offset losses from the drop in Acorda Therapeutics' long position.City View vs. Benchmark Botanics | City View vs. Speakeasy Cannabis Club | City View vs. BC Craft Supply | City View vs. Ravenquest Biomed |
Acorda Therapeutics vs. Shionogi Co | Acorda Therapeutics vs. Pacira BioSciences, | Acorda Therapeutics vs. Sunshine Biopharma Warrant | Acorda Therapeutics vs. Biofrontera |
Check out your portfolio center.Note that this page's information should be used as a complementary analysis to find the right mix of equity instruments to add to your existing portfolios or create a brand new portfolio. You can also try the Stocks Directory module to find actively traded stocks across global markets.
Other Complementary Tools
Funds Screener Find actively-traded funds from around the world traded on over 30 global exchanges | |
Technical Analysis Check basic technical indicators and analysis based on most latest market data | |
Money Managers Screen money managers from public funds and ETFs managed around the world | |
Equity Valuation Check real value of public entities based on technical and fundamental data | |
Performance Analysis Check effects of mean-variance optimization against your current asset allocation |